Accuray and Limbus AI Inc. Partner to Leverage Limbus’ Innovative AI-driven Technology to Enhance Accuray Adaptive Radiotherapy Solutions
Partnership will Enable Accuray to Use Limbus’ Technology to Streamline the Treatment Planning Process and Increase Operational Efficiency
Excerpt from the Press Release:
SUNNYVALE, Calif. and SASKATCHEWAN, Canada, June 2, 2022 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) and Limbus AI Inc. announced today they are partnering to augment Accuray adaptive radiotherapy capabilities by leveraging Limbus’ artificial intelligence (AI)-driven autocontouring algorithms – enabling automated contouring to further streamline the treatment planning process*. The companies expect an integrated offering to be made available beginning in 2023.
Changes in tumor size, shape and location, or in the position of organs and other healthy tissue due to weight gain or loss during the course of radiation therapy, may require adaptation of the treatment plan to ensure the radiation dose remains targeted on the tumor while avoiding nearby sensitive organs. Modifications to plans as part of the adaptive workflow, however, can be prohibitively time consuming and labor intensive. Contouring – defining the border of the tumor and organs at risk – is one of the most critical steps in the planning process and accounts for a significant proportion of both the personnel and time involved in plan adaptation.
Automating the contouring portion of the overall planning process opens the door to practical adaptive plan modification, when warranted, for any patient undergoing treatment, without overwhelming already stretched clinical staff. High-quality automation tools such as the one developed by Limbus AI for contouring also make it easier for medical care teams to ensure consistency in the plans created.
Click the button below to read the entire Press Release:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?